UBS Maintains Neutral on Clorox, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 61.5%

Neg 0% Neu 0% Pos 61.5%

UBS analyst Peter Grom maintains Clorox (NYSE:CLX) with a Neutral and raises the price target from $96 to $100.

Comments

No comments yet. Be the first!